WallStreetZenWallStreetZen

NYSE: PFE
Pfizer Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnershipStatistics
Pfizer earnings were $9.8B for the trailing 12 months ending Sep 28, 2025, with 126.3% growth year over year. The latest PFE earnings report on Sep 28, 2025 announced Q3 2025 earnings of $3.5B, up 21.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PFE reported annual earnings of $8.0B, with 279% growth.

PFE past earnings growth

How has PFE's earnings growth performed historically?

Company
126.32%
Industry
343.58%
Market
55.53%
PFE's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
PFE's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
PFE's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

PFE earnings history

Current Revenue
$62.8B
Current Earnings
$9.8B
Current Profit Margin
15.7%
PFE's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

PFE Return on Equity

Current Company
10.9%
Current Industry
118.3%
Current Market
36.1%
PFE's Return on Equity (10.9%)... subscribe to Premium to read more.
High Return on Equity Performance

PFE undefined

Current Company
4.7%
Current Industry
11.9%
PFE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PFE announces earnings.

PFE undefined

Current Company
5.31%
Current Industry
19.9%
PFE's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PFE vs General Drug Manufacturer Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PFE$15.84B$9.83B+4.35%$1.72
GILD$13.67B$8.11B+46.04%$6.51
SNY$18.05B$10.74B-2.50%$4.34
AMGN$16.53B$7.01B+0.85%$13.03
BMY$12.94B$6.04B-33.86%$2.97
View Top General Drug Manufacturer Stocks

Pfizer Earnings Reports & History FAQ

What were Pfizer's earnings last quarter?

On PFE's earnings call on Invalid Date, Pfizer (NYSE: PFE) reported Q3 2025 earnings per share (EPS) of $0.62, up 21.52% year over year. Total PFE earnings for the quarter were $3.54 billion. In the same quarter last year, Pfizer's earnings per share (EPS) was $0.79.

If you're new to stock investing, here's how to buy Pfizer stock.

Is Pfizer profitable or losing money?

As of the last Pfizer earnings report, Pfizer is currently profitable. Pfizer's net profit (also called net income) for the twelve months ending Sep 28, 2025 was $9.83 billion, a 131.14% increase year over year.

What was PFE's earnings growth in the past year?

As of Pfizer's earnings date in Invalid Date, Pfizer's earnings has grown 126.32% year over year. This is 217.26 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 343.58%. PFE earnings in the past year totalled $9.83 billion.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.